CNVIF
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
CNVIF (CNVIF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.276x
Based on the latest financial reports, CNVIF (CNVIF) has a cash flow conversion efficiency ratio of 0.276x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.98 Million) by net assets ($-18.03 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CNVIF - Cash Flow Conversion Efficiency Trend (2024–2025)
This chart illustrates how CNVIF's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CNVIF Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CNVIF ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NTT System SA
WAR:NTT
|
0.057x |
|
Vranken-Pommery Monopole S.A.
LSE:0J7D
|
N/A |
|
Dharmaj Crop Guard Limited
NSE:DHARMAJ
|
0.001x |
|
Chesapeake Gold Corp.
OTCQX:CHPGF
|
-0.008x |
|
Avision Inc
TW:2380
|
-0.031x |
|
Inmobiliaria Manquehue S.A
SN:MANQUEHUE
|
0.019x |
|
Ailleron S.A.
WAR:ALL
|
0.059x |
|
Sangji Caelum Inc
KQ:042940
|
-0.054x |
Annual Cash Flow Conversion Efficiency for CNVIF (2024–2025)
The table below shows the annual cash flow conversion efficiency of CNVIF from 2024 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $-18.03 Million | $-25.10 Million | 1.392x | +493.12% |
| 2024-09-30 | $-85.83 Million | $-20.15 Million | 0.235x | -- |